Psychiatric Symptoms in Metabolic and Other Genetic Disorders: Is Our "Organic" Workup Complete?

REFERENCES

• Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, vols I–IV. 8th ed. New York: McGraw-Hill, 2001.
   Google Scholar
• Von Wendt L, Similä S, Ruokonen A, Puukka M. Argininosuc- cinic aciduria in a Finnish woman presenting with psychosis and mental retardation. Ann Clin Res 1982;14:145–7.
   Google Scholar
• Estrov Y, Scaglia F, Bodamer OA. Psychiatric symptoms of in- herited metabolic disease. J Inherit Metab Dis 2000:23:2–6.
   PubMed Web of Science ®Google Scholar
• Abbott MH, Folstein SE, Abbey H, Pyeritz RE. Psychiatric man- ifestations of homocystinuria due to cystathionine β-synthase deficiency: prevalence, natural history, and relationship to neu- rologic impairment and vitamin B6-responsiveness. Am J Med Genet 1987;26:959–69.
   Web of Science ®Google Scholar
• Pietz J, Fatkenheuer B, Burgard P, Armbruster M, Esser G, Schmidt H. Psychiatric disorders in adult patients with early- treated phenylketonuria. Pediatrics 1977;99:345–50.
   Google Scholar
• Anonymous. Serving the family from birth to the medical home—newborn screening: a blueprint for the future. Pediatrics 2000;106(2, suppl S):389–427.
   Google Scholar
• McKusick VA. Heritable disorders of connective tissue. 4th ed. St. Louis: Mosby, 1972.
   Google Scholar
• Freeman JM, Finkelstein JD, Mudd SH. Folate-responsive ho- mocystinuria and “schizophrenia”: a defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity. N Engl J Med 1975;292:491–6.
   Google Scholar
• Mudd SH, Uhlendorf BW, Freeman JM, Finkelstein JD, Shih VE. Homocystinuria associated with decreased methylenete- trahydrofolate reductase activity. Biochem Biophys Res Com- mun 1972;46:905–12.
   PubMed Web of Science ®Google Scholar
• Brusilow SW, Horwich AL. Urea cycle enzymes. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, vol II. 8th ed. New York: McGraw- Hill, 2001:1909–63.
   Google Scholar
• Tuchman M, Knopman DS, Shih VE. Episodic hyperammone- mia in adult siblings with hyperornithinemia, hyperammone- mia, and homocitrullinuria syndrome. Arch Neurol 1990; 47:1134–7.
   Google Scholar
• Sweetman L, Williams JC. Branched chain organic acidurias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, vol II. 8th ed. New York: McGraw-Hill, 2001:2125–63.
   Google Scholar
• Jonas AJ, Butler IJ. Circumvention of defective neutral amino acid transport in Hartnup disease using tryptophan ethyl ester. J Clin Invest 1989;84:200–4.
   Google Scholar
• Levy HL. Hartnup disorder. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited dis- ease, vol III. 8th ed. New York: McGraw-Hill, 2001:4957–69.
   Google Scholar
• Hersov LA, Rodnight R. Hartnup disease in psychiatric practice: clinical and biochemical features of three cases. J Neurol Neuro- surg Psychiatry 1960;23:40–5.
   PubMed Web of Science ®Google Scholar
• Halvorsen K, Halvorsen S. Hartnup disease. Pediatrics 1963;31:29–38.
   Google Scholar
• Perry TL, Hansen S, Tischler B, Richards FM, Sokol M. Unrec- ognized adult phenylketonuria: implications for obstetrics and psychiatry. N Engl J Med 1973;289:395–8.
   Google Scholar
• Fisch RO, Hosfield WB, Chang PN, Barranger J, Hastings DW. An adult phenylketonuric with schizophrenia: clinical and bio- chemical similarities and possible genetic connection between the two disorders. Minnesota Med 1979;62:243–6.
   Google Scholar
• Reveley AM, Reveley MA. Screening for adult phenylketonuria in psychiatric inpatients. Biol Psychiatry 1982;17:1343–5.
   Google Scholar
• Dorninger F, Plöchl E. Patientin mit hebephrener Verlaufs- form einer Schizophrenie und später diagnostizierter Phenyl- ketonurie. Wien Zeitschr Nervenheilk 1969;27:328–37.
   Google Scholar
• Scriver CR, Kaufman S. Hyperphenylalaninemia: phenylala- nine hydroxylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited dis- ease, vol II. 8th ed. New York: McGraw-Hill, 2001:1667–724.
   Google Scholar
• Waisbren SE, Levy HL. Agoraphobia in phenylketonuria. J In- herit Metab Dis 1991;14:755–64.
   PubMed Web of Science ®Google Scholar
• Fisch RO, Chang PN, Weisberg S, Guldberg P, Güttler F, Tsai MY. Phenylketonuric patients decades after diet. J Inherit Metab Dis 1995;18:347–53.
   PubMed Web of Science ®Google Scholar
• Crimlisk HL. The little imitator—porphyria: a neuropsychiatric disorder. J Neurol Neurosurg Psychiatry 1997;62:319–28.
   PubMed Web of Science ®Google Scholar
• Burgoyne K, Swartz R, Ananth J. Porphyria: reexamination of psychiatric implications. Psychother Psychosom 1995;64:121–30.
   Google Scholar
• Hyde TM, Ziegler JC, Weinberger DR. Psychiatric disturbances in metachromatic leukodystrophy: insights into the neurobiol- ogy of psychosis. Arch Neurol 1992;49:401–6.
   PubMedGoogle Scholar
• Austin J, Armstrong D, Fouch S, Mitchell C, Stumpf D, Shearer L, et al. Metachromatic leukodystrophy, VIII: MLD in adults; diagnosis and pathogenesis. Arch Neurol 1968;18:225–40.
   Google Scholar
• Carey AH, Kelly D, Halford S, Wadey R, Wilson D, Goodship J, et al. Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. Am J Hum Genet 1992;51:964–70.
   PubMed Web of Science ®Google Scholar
• Driscoll DA, Spinner NB, Budarf ML, McDonald-McGinn DM, Zackai EH, Goldberg RB, et al. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J Med Genet 1992; 44:261–8.
   Google Scholar
• Devriendt K, Fryns JP, Mortier G, Van Thienen MN, Keymolen K. The annual incidence of DiGeorge/velocardiofacial syndrome [Letter]. J Med Genet 1998;35:789–90.
   PubMed Web of Science ®Google Scholar
• Du Montcel ST, Mendizabal H, Ayme S, Levy A, Philip N. Preva- lence of 22q11 microdeletion [Letter]. J Med Genet 1996;33:719.
   Web of Science ®Google Scholar
• Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, et al. Spectrum of clinical features associated with interstitial chro- mosome 22q11 deletions: a European collaborative study. J Med Genet 1997;34:798–804.
   PubMed Web of Science ®Google Scholar
• Shprintzen RJ, Goldberg RB, Lewin ML, Sidoti EJ, Berkman MD, Argamaso RV, et al. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo- cardio-facial syndrome. Cleft Palate J 1978;15:56–62.
   PubMedGoogle Scholar
• Goldberg R, Motzkin B, Marion R, Scambler PJ, Shprintzen RJ. Velo-cardio-facial syndrome: a review of 120 patients. Am J Med Genet 1993;45:313–9.
   PubMed Web of Science ®Google Scholar
• Swillen A, Vogels A, Devriendt K, Fryns JP. Chromosome 22q11 deletion syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications. Am J Med Genet 2000;97:128–35.
   PubMed Web of Science ®Google Scholar
• McDonald-McGinn DM, Kirschner R, Goldmuntz E, Sullivan K, Eicher P, Gerdes M, et al. The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns 1999;10:11–24.
   Google Scholar
• Papolos DF, Faedda GL, Veit S, Goldberg R, Morrow B, Kucher- lapati R, et al. Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 1996;153:1541–7.
   Google Scholar
• Carlson C, Papolos D, Pandita RK, Faedda GL, Veit S, Goldberg R, et al. Molecular analysis of velo-cardio-facial syndrome pa- tients with psychiatric disorders. Am J Med Genet 1997; 60:851–9.
   Google Scholar
• Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW. Late-onset psychosis in the velo-cardio-facial syndrome [Letter]. Am J Med Genet 1992;42:141–2.
   PubMed Web of Science ®Google Scholar
• Bassett AS, Hodgkinson K, Chow EW, Correia S, Scutt LE, Weksberg R. 22q11 deletion syndrome in adults with schizo- phrenia. Am J Med Genet 1998;81:328–37.
   PubMed Web of Science ®Google Scholar
• Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999;56:940–5.
   PubMed Web of Science ®Google Scholar
• Jessani N, Weller E, Weller R. Psychiatric syndromes in children and adolescents with velo-cardio-facial syndrome. Presented at the Second International Conference on 22q11.2 Deletion, Philadelphia, June 2000.
   Google Scholar
• Usiskin SI, Nicolson R, Krasnewich DM, Yan W, Lenane M, Wu- darsky M, et al. Velocardiofacial syndrome in childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 1999;38:1536–43.
   PubMedGoogle Scholar
• Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C. Neuro- psychiatric disorders in the 22q11 deletion syndrome. Genet Med 2001;3:79–84.
   PubMed Web of Science ®Google Scholar
• Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 1995;92:7612–6.
   PubMed Web of Science ®Google Scholar